MNMiyuki Nakatani

Miyuki Nakatani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miyuki Nakatani has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of simultaneous tandem drainage of intra-abdominal abscesses caused by gastrointestinal anastomotic failure

    by Yutaka Ueno, Shuji Kariya, Miyuki Nakatani, Yasuyuki Ono, Takuji Maruyama, Yuki Tanaka, Kanji Sugiura, Noboru Tanigawa

    Yutaka Ueno, Shuji Kariya, Miyuki Nakatani, Yasuyuki Ono, Takuji Maruyama, Yuki Tanaka, Kanji Sugiura, and Noboru Tanigawa. Int J Gastrointest Interv 2025;14:71-6. https://doi.org/10.18528/ijgii240080

  • Open Access

    The role of lymphatic interventional radiology for postoperative lymphorrhea

    by Shuji Kariya, Shintaro Yamamoto, Miyuki Nakatani, Yasuyuki Ono, Takuji Maruyama, Noboru Tanigawa


  • Open Access

    Force-velocity relationship profile of elbow flexors in male gymnasts

    by Miyuki Nakatani, Kensuke Murata, Hiroaki Kanehisa, Yohei Takai

    Background The theoretical maximum force (F0), velocity (V0), and power (Pmax) of athletes calculated from the relationship between force and velocity (F-V relationship) and the slope of the F-V relationship, reflect their competitive and training activity profiles. Evaluating the F-V relationship of athletes facilitates categorizing the profiles of dynamic muscle functions in relation to long-term sport-specific training. For gymnastics, however, no studies have tried to examine the profiles of F-V relation and power output for upper limb muscles in relation to the muscularity, while the use of the upper extremities in this sport is very unique as described earlier. Purpose It was hypothesized that the F-V relationship of the elbow flexion in gymnasts might be characterized by low capacity for generating explosive force, notably in terms of the force normalized to muscle size. Methods The F0, V0, and Pmax derived from the force-velocity relationship during explosive elbow flexion against six different loads (unloaded condition, 15, 30, 45, 60, and 75% of maximal voluntary isometric elbow flexion force (MVFEF)) for 16 gymnasts (GYM) and 22 judo athletes (JD). F0 and Pmax were expressed as values relative to the cross-sectional area index (CSAindex) of elbow flexors (F0/CSAindex and Pmax/CSAindex, respectively), which was calculated from muscle thickness in the anterior upper arm. The electromyogram (EMG) activities of the biceps brachii (BB) during the maximal isometric and dynamic tasks were also determined. Results There were no significant differences in CSAindex of elbow flexors between GYM and JD. MVFEF/CSAindex for GYM was significantly lower than that for JD. Force was linearly associated with velocity in the dynamic elbow flexion for all the participants (r = − 0.997 to −0.905 for GYM, r = − 0.998 to −0.840 for JD). F0, F0/ CSAindex, V0, Pmax, Pmax/CSAindex, and MVFEF were significantly lower in GYM than in JD. The activity levels of BB during the dynamic tasks tended to be lower in GYM than in JD at load of <45%MVC. Conclusion Gymnasts cannot generate explosive elbow flexion force corresponding to their muscle size. This may be due to low neuromuscular activities during the maximal dynamic tasks against relatively low loads.


  • Evaluation of the antithrombogenicity of poly-2-methoxyethylacrylate-coated catheters

    by Shuji Kariya, Miyuki Nakatani, Takuji Maruyama, Yasuyuki Ono, Yutaka Ueno, Atsushi Komemushi, Noboru Tanigawa

    The blood compatibility of indwelling intravascular catheters is facilitated by the use of antithrombogenic materials. Heparin has typically been used for this purpose; however, since heparin-coated catheters are considered combination products, difficulties meeting the relevant Food and Drug Administration safety recommendations have disrupted commercialization. Other issues include coating durability and the occurrence of heparin-induced thrombocytopenia. Polymer coatings are a potential alternative; however, polymer antithrombogenicity in circulating human blood has yet to be demonstrated. The present study aimed to establish the ex vivo antithrombogenicity of a poly-2-methoxyethylacrylate (PMEA) polymer coating applied to a central venous catheter using an artificial human blood circulation system. The present study used an artificial human blood circulation system to conduct an ex vivo evaluation of the antithrombogenicity of poly-2-methoxyethylacrylate (PMEA)-coated catheters. Human blood samples obtained from volunteer donors were loaded into a circulation system fitted with either a PMEA-coated or uncoated catheter. After 3-h, the catheter was removed and examined using scanning electron microscopy. Protein adsorption on the catheter surface was investigated by shredding the catheter that had contacted the blood inside the circulation system and immersing the pieces in 1 mL of 0.5 N NaOH for 2 days. The amount of protein in the 0.5 N NaOH was determined according to the Lowry method. Adherent fibrin, which forms a sheath on the catheter surface, was observed on uncoated, but not PMEA-coated catheters. Furthermore, the amount of protein adsorption was significantly less with PMEA-coated than uncoated catheters (p = 0.043). The present findings demonstrated the antithrombogenicity of PMEA-coated catheters in circulating human blood.